Recruiting Primary Biliary Cholangitis Studies in Englewood
About Primary Biliary Cholangitis Clinical Trials in Englewood
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the bile ducts in the liver are slowly destroyed. This leads to bile buildup, liver damage, and potentially cirrhosis. Treatment includes ursodeoxycholic acid and obeticholic acid.
There are currently 1 primary biliary cholangitis clinical trials recruiting participants in Englewood, CO. These studies are seeking a combined 276 participants. Research is being sponsored by Ipsen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Primary Biliary Cholangitis Clinical Trials in Englewood — FAQ
Are there primary biliary cholangitis clinical trials in Englewood?
Yes, there are 1 primary biliary cholangitis clinical trials currently recruiting in Englewood, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Englewood?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Englewood research site will contact you about next steps.
Are clinical trials in Englewood free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Englewood studies also compensate for your time and travel.
What primary biliary cholangitis treatments are being tested?
The 1 active trials in Englewood are testing new therapies including novel drugs, biologics, and treatment approaches for primary biliary cholangitis.
Data updated March 2, 2026 from ClinicalTrials.gov